VANCOUVER, British Columbia, Sept. 15, 2017 (GLOBE NEWSWIRE) — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N)(FRANKFURT:M5BQ)(OTCMKTS:NXTTF) is pleased to announce that its wholly owned subsidiary, Cannmart Inc. (“CannMart”), has signed a supply agreement (the “Agreement”) with Israeli-based producer Cannbit Ltd. (“Cannbit”).
The Agreement, subject to approval by Health Canada, will supply medical cannabis products sourced from Cannbit in Israel, to be sold exclusively in Canada through CannMart and Namaste sales channels. This Agreement represents a fundamental step in Namaste’s growth strategy to develop a marketplace for Canadian medical cannabis that will include product sourced both domestically and internationally.
Namaste will further pursue supply agreements with domestic and international producers in developing a unique online platform to provide a larger variety of medical cannabis products to patients sourced from domestic and international producers. Namaste recognizes that Israel is providing the medical cannabis industry with leading research and intends to provide Israeli-grown products to Canadian medical cannabis patients.
Sean Dollinger, President and CEO of Namaste comments: “We are very pleased to sign this Agreement. We had the opportunity of meeting with the Cannbit management team and feel very strongly that Namaste will bring some of the highest quality medical cannabis available in the world to our Canadian patients. Through our new platform, Namaste MD, we will be offering a full-service platform for users to flow through an initial consultation to issuance of a prescription. They will then be provided with access to our marketplace of medical cannabis products that will be sourced from multiple producers in Canada, as well as countries like Israel, that are innovators in research and development in our industry.”
About Namaste Technologies Inc.
Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 ecommerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.
On behalf of the Board of Directors
Chief Executive Officer
Direct: +1 (786) 389 9771
Further information on the Company and its products can be accessed through the links below:
FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.